BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22406360)

  • 1. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma.
    Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Geier C; Katenkamp D; Petersen I
    Hum Pathol; 2012 Sep; 43(9):1463-70. PubMed ID: 22406360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell melanoma: a cutaneous clear cell malignancy.
    Pletneva MA; Andea A; Palanisamy N; Betz BL; Carskadon S; Wang M; Patel RM; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2014 Oct; 138(10):1328-36. PubMed ID: 25268196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses).
    Panagopoulos I; Mertens F; Isaksson M; Mandahl N
    Cancer Genet Cytogenet; 2005 Jan; 156(1):74-6. PubMed ID: 15588860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
    Langezaal SM; Graadt van Roggen JF; Cleton-Jansen AM; Baelde JJ; Hogendoorn PC
    Br J Cancer; 2001 Feb; 84(4):535-8. PubMed ID: 11207050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.
    Song JS; Choi J; Kim JH; Jang SJ; Cho KJ
    Pathol Int; 2010 Sep; 60(9):608-13. PubMed ID: 20712646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
    Covinsky M; Gong S; Rajaram V; Perry A; Pfeifer J
    Hum Pathol; 2005 Jan; 36(1):74-81. PubMed ID: 15712185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.
    Antonescu CR; Dal Cin P; Nafa K; Teot LA; Surti U; Fletcher CD; Ladanyi M
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1051-60. PubMed ID: 17724745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma.
    Lyle PL; Amato CM; Fitzpatrick JE; Robinson WA
    Am J Surg Pathol; 2008 Jun; 32(6):858-66. PubMed ID: 18408594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.
    Saldanha G; Potter L; Daforno P; Pringle JH
    Clin Cancer Res; 2006 Aug; 12(15):4499-505. PubMed ID: 16899595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
    Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
    Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.
    Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T
    Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
    Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell sarcoma of soft tissue: diagnostic utility of fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction.
    Curry CV; Dishop MK; Hicks MJ; Naeem R; Reed JA; López-Terrada DH
    J Cutan Pathol; 2008 Apr; 35(4):411-7. PubMed ID: 18333903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
    Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
    Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
    Coindre JM; Hostein I; Terrier P; Bouvier-Labit C; Collin F; Michels JJ; Trassard M; Marques B; Ranchere D; Guillou L
    Cancer; 2006 Sep; 107(5):1055-64. PubMed ID: 16878328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma.
    Devitt B; Liu W; Salemi R; Wolfe R; Kelly J; Tzen CY; Dobrovic A; McArthur G
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):666-72. PubMed ID: 21615881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma.
    Hantschke M; Mentzel T; Rütten A; Palmedo G; Calonje E; Lazar AJ; Kutzner H
    Am J Surg Pathol; 2010 Feb; 34(2):216-22. PubMed ID: 20087159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.